H.B. Fuller shares dropped to a new 52-week low of $48.60 despite reporting better-than-expected quarterly earnings. The decline coincided with significant insider selling by VP Nathan Weaver, contras
H.B. Fuller is set to report Q3 2026 earnings on September 23rd, with analysts forecasting $1.47 EPS and $948.2 million revenue. The stock maintains a Buy consensus with a price target of $67.86 follo
H.B. Fuller Company will release its Q3 2026 financial results after market close on September 23, 2026. An investor conference call and webcast will follow on September 24 to discuss the findings.
H.B. Fuller received a consensus 'Buy' rating from analysts after reporting quarterly earnings of $1.41 EPS against estimates, with revenue growing 5.8% year-over-year.
H.B. Fuller is expanding Gel-Tac™ microsphere adhesive production at its Italian Pianezze facility to enhance supply responsiveness and reduce carbon footprints. Additionally, the company is developin
H.B. Fuller rejected Ancora Holdings Group's $1.2 billion offer for its Building Adhesives Solutions business, citing undervaluation and operational dis-synergies. The company plans to demonstrate the
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora Holdings Group targeting its Building Adhesives Solutions business. The company reported full-year net sales of
H.B. Fuller rejected a $1.1–1.2 billion offer from activist investor Ancora Group Holdings for its building adhesive solutions unit, citing undervaluation. Ancora reaffirmed its intent to acquire desp
H.B. Fuller's board unanimously rejected an unsolicited acquisition proposal from Ancora for its Building Adhesives Solutions business, citing undervaluation. The company will continue its strategic a
H.B. Fuller rejected Ancora Holdings' $1.2 billion unsolicited offer for its Building Adhesive Solutions business, citing undervaluation. The board remains firm despite Ancora's criticism and potentia
H.B. Fuller rejected Ancora's $1.2 billion offer for its building adhesives unit, citing undervaluation. The activist investor argued the sale would reduce debt and address governance concerns regardi
H.B. Fuller's board has reportedly rejected Ancora's $1.2 billion bid for its building adhesives solutions segment. The decision follows earlier reports that Engine Capital had urged the company to en
H.B. Fuller rejected Ancora Holdings' $1.2 billion bid for its building adhesives unit, citing undervaluation. Shares remained flat as the board deemed the proposal lacked key growth information.
H.B. Fuller director Teresa J. Rasmussen Trangsrud purchased 1,000 shares worth $65,830. The company is also considering a $1.2 billion acquisition proposal.
H.B. Fuller director Teresa J. Rasmussen Trangsrud bought 1,000 shares at $65.83/share on April 17, 2026, raising her holdings to 3,391 shares per amended Form 4 filing.
S&CO Inc. acquired a $14.1 million stake in H.B. Fuller Company, which recently exceeded quarterly earnings expectations with $1.41 EPS and $950.27 million in revenue.
Activist investor Engine Capital is urging H.B. Fuller's board to conduct a market check for its Building Adhesive Solutions segment and the entire company. This move signals a push to explore strateg
H.B. Fuller received an unsolicited $1.1–$1.2 billion cash offer from Ancora Holdings to acquire its Building Adhesives Solutions business. The board will evaluate the proposal with financial and lega
H.B. Fuller has received an unsolicited $1.1–1.2 billion cash offer from Ancora Holdings Group for its Building Adhesives Solutions business. The board will evaluate the proposal with financial advise
H.B. Fuller confirmed an unsolicited cash offer from Ancora Holdings to acquire its building adhesives business for $1.1 billion to $1.2 billion. The proposal follows earlier reports of verbal interes
H.B. Fuller Company submitted an SEC Form 144 filing proposing the sale of 9,561 common stock shares acquired through employee options, totaling approximately $593,332.
Heather Campe, Senior VP of International Growth at H.B. Fuller, received 40,280 phantom units valued at $55.30 per unit on July 31, 2026.
Sei Investments Co. increased its stake in H.B. Fuller by 19.2% to $11.6 million, following strong quarterly earnings and a Moderate Buy rating from analysts.
This article details key metrics for H.B. Fuller Company's bond HBFL5059230, including coupon rates and maturity dates. It also outlines the company's business segments focusing on hygiene, health, an
H.B. Fuller (NYSE: FUL) will go ex-dividend on July 30, 2026, paying $0.245 per share. This announcement marks a key investor event for the specialty chemicals firm.
H.B. Fuller Company reported €3.00 billion in total revenue last year, with the Hygiene, Health and Consumable Adhesives segment leading performance. The United States was the top regional contributor
H.B. Fuller Company reported regional revenue shares as of April 6, 2026, with the Americas leading at 50.33% and EIMEA at 30.22%, though segment data remains undisclosed.
H.B. Fuller Company (FUL) shares traded at $55.78, down 1.33%. As a pure-play adhesives firm, it manufactures specialty chemical products for hygiene, health, engineering, and construction segments.
H.B. Fuller secured new Term A loans and expanded credit capacity while extending maturities to 2031. The board declared a quarterly dividend of $0.2450 per share to improve liquidity.
H.B. Fuller Company shares rose 0.96% to $55.70, maintaining healthy fundamentals and a 1.69% dividend yield. Analysts retain a Buy rating with a $73.91 target, indicating 34% upside potential.
The article identifies five value stocks, including chemical firm H.B. Fuller, based on favorable EV-to-EBITDA ratios and strong financial metrics, highlighting potential undervalued opportunities.
H.B. Fuller Company has refinanced its senior credit facilities, increasing the revolving credit facility to $800 million with maturity extended to July 2031. The amendment reduces interest rate margi
H.B. Fuller amended its credit agreement with JPMorgan Chase, extending loan maturities to July 2031 and increasing the revolving facility to $800 million. The refinancing reduces interest rate margin
H.B. Fuller has published a scheme document for its recommended cash acquisition of Advanced Medical Solutions Group PLC. The deal is expected to complete in Q3 or Q4 2026 following shareholder approv
Advanced Medical Solutions Group plc published a scheme document detailing H.B. Fuller's recommended cash acquisition, with shareholders voting on August 12, 2026, and completion expected in late 2026
H.B. Fuller Company announced a regular quarterly cash dividend of $0.245 per common share, payable on August 1, 2024, to shareholders of record as of July 18, 2024.
H.B. Fuller declared a $0.245 quarterly dividend, extending its 57-year increase streak. Analysts rate the stock Moderate Buy after the company beat earnings expectations.
H.B. Fuller granted director Thomas W. Handley 2,894.74 deferred stock units at $57 per unit under a deferred compensation plan convertible to common stock upon retirement.
H.B. Fuller director Michael J. Happe received 2,894.74 stock units valued at $57 per unit on July 15, 2026, increasing his direct holdings under a deferred compensation plan.
H.B. Fuller stock performance was analyzed based on operating figures released on July 16, 2026. The report links financial results to adhesives demand across various applications.
H.B. Fuller declared a quarterly dividend of $0.245 per share, continuing a 33-year growth streak. Analysts cite rising raw material costs and acquisition plans alongside positive financial results.
H.B. Fuller declared a regular quarterly cash dividend of $0.2450 per share payable on August 13, 2026, continuing its 58-year history of payments.
H.B. Fuller declared a quarterly cash dividend of $0.245 per share payable on August 13, 2026, continuing its 58-year streak of regular payments.
Dimensional Fund Advisors LP disclosed a 5.3% beneficial ownership stake in HB Fuller Co, holding 2.8 million shares via client funds. The firm retains sole voting power over most shares while disclai
H.B. Fuller Company submitted a Form 4 filing on July 10 detailing insider transactions, while its stock showed positive performance on the publication day.
H.B. Fuller Senior Vice President Joao Magalhaes exercised employee stock options to acquire 1,658 shares at $50.10 per share. Following the transaction, his direct holdings total 5,523 common shares.
H.B. Fuller Senior Vice President Heather Campe was granted 38,150 phantom units tied to common stock as part of her equity compensation package. The filing details her total direct holdings and vario
HB Fuller Company disclosed insider transactions via a Form 4 filing on July 7, noting associated stock performance metrics.
H.B. Fuller Company aims to balance adhesives growth with earnings amidst fluctuating industrial demand. The company leverages its diverse portfolio in manufacturing, building, and packaging while foc
H.B. Fuller reported stronger Q2 results and completed a $134.32 million share repurchase program. Activist investor pressure on governance and performance now influences the company's investment outl
ChemBrief